Human Molecular Genetics, 2000, Vol. 9, No. 19 2799-2809
© 2000 Oxford University Press
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA, 1Institute of Pharmacological Sciences, University of Milano, 20133 Milano, Italy and 2Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Lengthening a glutamine tract in huntingtin confers a dominant attribute that initiates degeneration of striatal neurons in Huntingtons disease (HD). To identify pathways that are candidates for the mutant proteins abnormal function, we compared striatal cell lines established from wild-type and HdhQ111 knock-in embryos. Alternate versions of full-length huntingtin, distinguished by epitope accessibility, were localized to different sets of nuclear and perinuclear organelles involved in RNA biogenesis and membrane trafficking. However, mutant STHdhQ111 cells also exhibited additional forms of the full-length mutant protein and displayed dominant phenotypes that did not mirror phenotypes caused by either huntingtin deficiency or excess. These phenotypes indicate a disruption of striatal cell homeostasis by the mutant protein, via a mechanism that is separate from its normal activity. They also support specific stress pathways, including elevated p53, endoplasmic reticulum stress response and hypoxia, as potential players in HD.
+ To whom correspondence should be addressed: Tel: +1 617 726 5089; Fax: +1 617 726 5735; Email: macdonam@helix.mgh.harvard.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Raspe, J. Gillis, H. Krol, S. Krom, K. Bosch, H. van Veen, and E. Reits Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity J. Cell Sci., September 15, 2009; 122(18): 3262 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carnemolla, E. Fossale, E. Agostoni, S. Michelazzi, R. Calligaris, L. De Maso, G. Del Sal, M. E. MacDonald, and F. Persichetti Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease J. Biol. Chem., July 3, 2009; 284(27): 18167 - 18173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subramaniam, K. M. Sixt, R. Barrow, and S. H. Snyder Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity Science, June 5, 2009; 324(5932): 1327 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. del Toro, J. Alberch, F. Lazaro-Dieguez, R. Martin-Ibanez, X. Xifro, G. Egea, and J. M. Canals Mutant Huntingtin Impairs Post-Golgi Trafficking to Lysosomes by Delocalizing Optineurin/Rab8 Complex from the Golgi Apparatus Mol. Biol. Cell, March 1, 2009; 20(5): 1478 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zala, E. Colin, H. Rangone, G. Liot, S. Humbert, and F. Saudou Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons Hum. Mol. Genet., December 15, 2008; 17(24): 3837 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Duennwald and S. Lindquist Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity Genes & Dev., December 1, 2008; 22(23): 3308 - 3319. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Benn, T. Sun, G. Sadri-Vakili, K. N. McFarland, D. P. DiRocco, G. J. Yohrling, T. W. Clark, B. Bouzou, and J.-H. J. Cha Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner J. Neurosci., October 15, 2008; 28(42): 10720 - 10733. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paoletti, I. Vila, M. Rife, J. M. Lizcano, J. Alberch, and S. Gines Dopaminergic and Glutamatergic Signaling Crosstalk in Huntington's Disease Neurodegeneration: The Role of p25/Cyclin-Dependent Kinase 5 J. Neurosci., October 1, 2008; 28(40): 10090 - 10101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Quintanilla, Y. N. Jin, K. Fuenzalida, M. Bronfman, and G. V. W. Johnson Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} (PPAR{gamma}) IN THE PATHOGENESIS OF HUNTINGTON DISEASE J. Biol. Chem., September 12, 2008; 283(37): 25628 - 25637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kortlever, T. R. Brummelkamp, L. A. van Meeteren, W. H. Moolenaar, and R. Bernards Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling Mol. Cancer Res., September 1, 2008; 6(9): 1452 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies PNAS, August 5, 2008; 105(31): 10820 - 10825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-O. Kim, P. Chawla, R. P. Overland, E. Xia, G. Sadri-Vakili, and J.-H. J. Cha Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation J. Neurosci., April 9, 2008; 28(15): 3947 - 3957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease J. Biol. Chem., February 29, 2008; 283(9): 5780 - 5789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Atwal, J. Xia, D. Pinchev, J. Taylor, R. M. Epand, and R. Truant Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity Hum. Mol. Genet., November 1, 2007; 16(21): 2600 - 2615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rigamonti, D. Bolognini, C. Mutti, C. Zuccato, M. Tartari, F. Sola, M. Valenza, A. G. Kazantsev, and E. Cattaneo Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators J. Biol. Chem., August 24, 2007; 282(34): 24554 - 24562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lumsden, T. L. Henshall, S. Dayan, M. T. Lardelli, and R. I. Richards Huntingtin-deficient zebrafish exhibit defects in iron utilization and development Hum. Mol. Genet., August 15, 2007; 16(16): 1905 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Anne, F. Saudou, and S. Humbert Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons J. Neurosci., July 4, 2007; 27(27): 7318 - 7328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zuccato, N. Belyaev, P. Conforti, L. Ooi, M. Tartari, E. Papadimou, M. MacDonald, E. Fossale, S. Zeitlin, N. Buckley, et al. Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease J. Neurosci., June 27, 2007; 27(26): 6972 - 6983. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sadri-Vakili, B. Bouzou, C. L. Benn, M.-O. Kim, P. Chawla, R. P. Overland, K. E. Glajch, E. Xia, Z. Qiu, S. M. Hersch, et al. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models Hum. Mol. Genet., June 1, 2007; 16(11): 1293 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dompierre, J. D. Godin, B. C. Charrin, F. P. Cordelieres, S. J. King, S. Humbert, and F. Saudou Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation J. Neurosci., March 28, 2007; 27(13): 3571 - 3583. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rockabrand, N. Slepko, A. Pantalone, V. N. Nukala, A. Kazantsev, J. L. Marsh, P. G. Sullivan, J. S. Steffan, S. L. Sensi, and L. M. Thompson The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis Hum. Mol. Genet., January 1, 2007; 16(1): 61 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. del Toro, J. M. Canals, S. Gines, M. Kojima, G. Egea, and J. Alberch Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism J. Neurosci., December 6, 2006; 26(49): 12748 - 12757. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Milakovic, R. A. Quintanilla, and G. V. W. Johnson Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells: FUNCTIONAL CONSEQUENCES J. Biol. Chem., November 17, 2006; 281(46): 34785 - 34795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. A. Oliveira, S. Chen, S. Almeida, R. Riley, J. Goncalves, C. R. Oliveira, M. R. Hayden, D. G. Nicholls, L. M. Ellerby, and A. C. Rego Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors J. Neurosci., October 25, 2006; 26(43): 11174 - 11186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shibata, T. Lu, T. Furuya, A. Degterev, N. Mizushima, T. Yoshimori, M. MacDonald, B. Yankner, and J. Yuan Regulation of Intracellular Accumulation of Mutant Huntingtin by Beclin 1 J. Biol. Chem., May 19, 2006; 281(20): 14474 - 14485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci., April 26, 2006; 26(17): 4649 - 4659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pal, F. Severin, B. Lommer, A. Shevchenko, and M. Zerial Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J. Cell Biol., February 13, 2006; 172(4): 605 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pardo, E. Colin, E. Regulier, P. Aebischer, N. Deglon, S. Humbert, and F. Saudou Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421 J. Neurosci., February 1, 2006; 26(5): 1635 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jin, M. LaFevre-Bernt, Y. Sun, S. Chen, J. Gafni, D. Crippen, A. Logvinova, C. A. Ross, D. A. Greenberg, and L. M. Ellerby FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease PNAS, December 13, 2005; 102(50): 18189 - 18194. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Anborgh, C. Godin, M. Pampillo, G. K. Dhami, L. B. Dale, S. P. Cregan, R. Truant, and S. S. G. Ferguson Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin J. Biol. Chem., October 14, 2005; 280(41): 34840 - 34848. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Seong, E. Ivanova, J.-M. Lee, Y. S. Choo, E. Fossale, M. Anderson, J. F. Gusella, J. M. Laramie, R. H. Myers, M. Lesort, et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism Hum. Mol. Genet., October 1, 2005; 14(19): 2871 - 2880. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Milakovic and G. V. W. Johnson Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin J. Biol. Chem., September 2, 2005; 280(35): 30773 - 30782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Choo, G. V.W. Johnson, M. MacDonald, P. J. Detloff, and M. Lesort Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release Hum. Mol. Genet., July 15, 2004; 13(14): 1407 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ruan, M. Lesort, M. E. MacDonald, and G. V.W. Johnson Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway Hum. Mol. Genet., April 1, 2004; 13(7): 669 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prince, S. Carreira, K. W. Vance, A. Abrahams, and C. R. Goding Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor Cancer Res., March 1, 2004; 64(5): 1669 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gines, E. Ivanova, I.-S. Seong, C. A. Saura, and M. E. MacDonald Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells J. Biol. Chem., December 12, 2003; 278(50): 50514 - 50522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. MacDonald Huntingtin: Alive and Well and Working in Middle Management Sci. Signal., November 4, 2003; 2003(207): pe48 - pe48. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xia, D. H. Lee, J. Taylor, M. Vandelft, and R. Truant Huntingtin contains a highly conserved nuclear export signal Hum. Mol. Genet., June 15, 2003; 12(12): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. G. Dirac and R. Bernards Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53 J. Biol. Chem., March 28, 2003; 278(14): 11731 - 11734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gines, I. S. Seong, E. Fossale, E. Ivanova, F. Trettel, J. F. Gusella, V. C. Wheeler, F. Persichetti, and M. E. MacDonald Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice Hum. Mol. Genet., March 1, 2003; 12(5): 497 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fossale, V. C. Wheeler, V. Vrbanac, L.-A. Lebel, A. Teed, J. S. Mysore, J. F. Gusella, M. E. MacDonald, and F. Persichetti Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice Hum. Mol. Genet., September 15, 2002; 11(19): 2233 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luthi-Carter, S. A. Hanson, A. D. Strand, D. A. Bergstrom, W. Chun, N. L. Peters, A. M. Woods, E. Y. Chan, C. Kooperberg, D. Krainc, et al. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain Hum. Mol. Genet., August 15, 2002; 11(17): 1911 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Wheeler, C.-A. Gutekunst, V. Vrbanac, L.-A. Lebel, G. Schilling, S. Hersch, R. M. Friedlander, J. F. Gusella, J.-P. Vonsattel, D. R. Borchelt, et al. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice Hum. Mol. Genet., March 1, 2002; 11(6): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Brummelkamp, R. M. Kortlever, M. Lingbeek, F. Trettel, M. E. MacDonald, M. van Lohuizen, and R. Bernards TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19ARF and Inhibits Senescence J. Biol. Chem., February 15, 2002; 277(8): 6567 - 6572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Davies and D B Ramsden Huntington's disease Mol. Pathol., December 1, 2001; 54(6): 409 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zuccato, A. Ciammola, D. Rigamonti, B. R. Leavitt, D. Goffredo, L. Conti, M. E. MacDonald, R. M. Friedlander, V. Silani, M. R. Hayden, et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease Science, July 20, 2001; 293(5529): 493 - 498. [Abstract] [Full Text] [PDF] |
||||












